Covella Pharmaceuticals Overview
- Founded
- 2007
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Financing Rounds
- 1
Covella Pharmaceuticals General Information
Description
Provider of bio-technical services. The company engages in providing VLA-1 neutralizing antibodies for the multiple inflammatory and autoimmune diseases.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
- DE
- United States
Covella Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Covella Pharmaceuticals‘s full profile, request access.
Request a free trialCovella Pharmaceuticals Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Mark Totoritis MD | Co-Founder | ||
| Matthew Strobeck Ph.D | Co-Founder |